• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用生物物理和结构方法研究人 c-MYC 的 bHLHZip 区域。

Biophysical and Structural Methods to Study the bHLHZip Region of Human c-MYC.

机构信息

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.

出版信息

Methods Mol Biol. 2021;2318:21-43. doi: 10.1007/978-1-0716-1476-1_3.

DOI:10.1007/978-1-0716-1476-1_3
PMID:34019285
Abstract

The C-terminal region of the c-MYC transcription factor consists of approximately 100 amino acids that in its native state does not adopt a stable structure. When this region binds to the obligatory partner MAX via a coupled folding-and-binding mechanism, it forms a basic-helix-loop-helix-leucine zipper (bHLHZip) heterodimeric complex. The C-terminal region of MYC is the target for numerous drug discovery programs for direct MYC inhibition via blocking the dimerization event and/or binding to DNA, and a proper understanding of the partially folded, dynamic nature of the heterodimeric complex is essential to these efforts. The bHLHZip motif also drives protein-protein interactions with cofactors that are crucial for both transcriptional repression and activation of MYC target genes. Targeting these interactions could potentially provide a means of developing alternative approaches to halt MYC functions; however, the molecular mechanism of these regulatory interactions is poorly understood. Herein we provide methods to produce high-quality human c-MYC C-terminal by itself and in complex MAX, and how to study them using Nuclear Magnetic Resonance spectroscopy and X-ray crystallography. Our protein expression and purification protocols have already been used to study interactions with cofactors.

摘要

c-MYC 转录因子的 C 端区域由大约 100 个氨基酸组成,在其自然状态下不具有稳定的结构。当这个区域通过耦合折叠和结合机制与必需的伴侣 MAX 结合时,它形成一个碱性-螺旋-环-螺旋-亮氨酸拉链(bHLHZip)异二聚体复合物。MYC 的 C 端区域是许多药物发现计划的目标,这些计划通过阻断二聚化事件和/或与 DNA 结合来直接抑制 MYC,对异二聚体复合物的部分折叠、动态性质的正确理解对于这些努力至关重要。bHLHZip 基序还驱动与辅因子的蛋白质-蛋白质相互作用,这些辅因子对于 MYC 靶基因的转录抑制和激活都至关重要。针对这些相互作用可能提供了一种开发替代方法来阻止 MYC 功能的手段;然而,这些调节相互作用的分子机制尚未被很好地理解。本文提供了生产高质量人 c-MYC C 端自身及其与 MAX 复合物的方法,以及如何使用核磁共振波谱学和 X 射线晶体学研究它们的方法。我们的蛋白质表达和纯化方案已经用于研究与辅因子的相互作用。

相似文献

1
Biophysical and Structural Methods to Study the bHLHZip Region of Human c-MYC.用生物物理和结构方法研究人 c-MYC 的 bHLHZip 区域。
Methods Mol Biol. 2021;2318:21-43. doi: 10.1007/978-1-0716-1476-1_3.
2
Crystal Structures and Nuclear Magnetic Resonance Studies of the Apo Form of the c-MYC:MAX bHLHZip Complex Reveal a Helical Basic Region in the Absence of DNA.无 DNA 结合时 c-MYC:MAX 异二聚体的 apo 形式的晶体结构和核磁共振研究揭示碱性区呈螺旋状
Biochemistry. 2019 Jul 23;58(29):3144-3154. doi: 10.1021/acs.biochem.9b00296. Epub 2019 Jul 11.
3
Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.致癌转录因子v-Myc二聚化及DNA结合结构域的结构、功能与动力学
J Mol Biol. 2001 Apr 13;307(5):1395-410. doi: 10.1006/jmbi.2001.4537.
4
Reconstitution of an E box-binding Myc:Max complex with recombinant full-length proteins expressed in Escherichia coli.用在大肠杆菌中表达的重组全长蛋白重建E盒结合Myc:Max复合物。
Protein Expr Purif. 2004 Apr;34(2):215-22. doi: 10.1016/j.pep.2003.11.021.
5
Methods of Expression, Purification, and Preparation of the c-Myc b-HLH-LZ for Its Biophysical Characterization.表达、纯化和制备 c-Myc b-HLH-LZ 的方法及其生物物理特性的研究。
Methods Mol Biol. 2021;2318:13-19. doi: 10.1007/978-1-0716-1476-1_2.
6
Design and properties of a Myc derivative that efficiently homodimerizes.一种能有效同源二聚化的Myc衍生物的设计与特性
Oncogene. 1998 Nov 12;17(19):2463-72. doi: 10.1038/sj.onc.1202199.
7
New structural determinants for c-Myc specific heterodimerization with Max and development of a novel homodimeric c-Myc b-HLH-LZ.新型 c-Myc 与 Max 特异性异二聚体的结构决定因素及新型 c-Myc 同源二聚体 b-HLH-LZ 的开发。
J Mol Recognit. 2012 Jul;25(7):414-26. doi: 10.1002/jmr.2203.
8
Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.Mga,一种与Max相互作用的双特异性转录因子,含有一个T结构域DNA结合基序。
EMBO J. 1999 Dec 15;18(24):7019-28. doi: 10.1093/emboj/18.24.7019.
9
Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.从c-Myc-Max异源二聚体亮氨酸拉链的1H-NMR溶液结构洞察异源二聚化机制。
J Mol Biol. 1998 Aug 7;281(1):165-81. doi: 10.1006/jmbi.1998.1914.
10
The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.Myc原癌蛋白的碱性区域/螺旋-环-螺旋/亮氨酸拉链结构域:功能与调控
Oncogene. 1999 May 13;18(19):2955-66. doi: 10.1038/sj.onc.1202750.

本文引用的文献

1
Mission Possible: Advances in MYC Therapeutic Targeting in Cancer.使命必达:癌症中 MYC 治疗靶点的新进展。
BioDrugs. 2019 Oct;33(5):539-553. doi: 10.1007/s40259-019-00370-5.
2
Crystal Structures and Nuclear Magnetic Resonance Studies of the Apo Form of the c-MYC:MAX bHLHZip Complex Reveal a Helical Basic Region in the Absence of DNA.无 DNA 结合时 c-MYC:MAX 异二聚体的 apo 形式的晶体结构和核磁共振研究揭示碱性区呈螺旋状
Biochemistry. 2019 Jul 23;58(29):3144-3154. doi: 10.1021/acs.biochem.9b00296. Epub 2019 Jul 11.
3
Unmasking the Mysteries of MYC.
揭开MYC的神秘面纱。
J Immunol. 2019 May 1;202(9):2517-2518. doi: 10.4049/jimmunol.1900186.
4
The structure of INI1/hSNF5 RPT1 and its interactions with the c-MYC:MAX heterodimer provide insights into the interplay between MYC and the SWI/SNF chromatin remodeling complex.INI1/hSNF5 RPT1 的结构及其与 c-MYC:MAX 异二聚体的相互作用为我们深入了解 MYC 和 SWI/SNF 染色质重塑复合物之间的相互作用提供了线索。
FEBS J. 2018 Nov;285(22):4165-4180. doi: 10.1111/febs.14660. Epub 2018 Oct 1.
5
The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis.MYC 转录因子网络:平衡代谢、增殖和致癌作用。
Front Med. 2018 Aug;12(4):412-425. doi: 10.1007/s11684-018-0650-z. Epub 2018 Jul 27.
6
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.Myc通过调控炎症和免疫抑制与Ras协同作用。
Cell. 2017 Nov 30;171(6):1301-1315.e14. doi: 10.1016/j.cell.2017.11.013.
7
Strategies to Inhibit Myc and Their Clinical Applicability.抑制Myc的策略及其临床应用
Front Cell Dev Biol. 2017 Feb 23;5:10. doi: 10.3389/fcell.2017.00010. eCollection 2017.
8
Targeting MYC: is it getting any easier?靶向MYC:这会变得更容易吗?
Future Med Chem. 2016 Oct;8(16):1899-1902. doi: 10.4155/fmc-2016-0119. Epub 2016 Sep 21.
9
Different promoter affinities account for specificity in MYC-dependent gene regulation.不同的启动子亲和力决定了MYC依赖性基因调控的特异性。
Elife. 2016 Jul 27;5:e15161. doi: 10.7554/eLife.15161.
10
Therapeutic strategies to inhibit MYC.抑制MYC的治疗策略。
Cold Spring Harb Perspect Med. 2014 Oct 1;4(10):a014266. doi: 10.1101/cshperspect.a014266.